Global Hemostatic Agents Market - 2024-2032
The Global Hemostatic Agents Market was valued at US$ 3.01 billion in 2024 and is anticipated to reach US$ 4.15 billion by 2032, at a CAGR of 0.042 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Global Hemostatic Agents Market.
This report delivers a comprehensive overview of the Global Hemostatic Agents Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Global Hemostatic Agents Market. The Global Hemostatic Agents Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
Global Hemostatic Agents Market Scope:
By Material
This report delivers a comprehensive overview of the Global Hemostatic Agents Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Global Hemostatic Agents Market. The Global Hemostatic Agents Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Global Hemostatic Agents Market.
This report delivers a comprehensive overview of the Global Hemostatic Agents Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Global Hemostatic Agents Market. The Global Hemostatic Agents Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
Global Hemostatic Agents Market Scope:
By Material
- Chitosan-based
- Gelatine-based
- Collagen-based
- Oxidized Regenerated Cellulose (ORC)
- Flowable Hemostats
- Others
- Powder
- Gel
- Sponges
- Matrix
- Sheets & Pads
- Topical
- Intravenous
- Others
- General Surgery
- Cardiovascular Surgery
- Orthopedic Surgery
- Others
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
- Becton, Dickinson, and Company
- Aegis Lifesciences
- Baxter
- Teleflex Incorporated
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- 3-D Matrix Medical Technology
- Medcura
- Ferrosan Medical Devices A/S
- Delta Surgical
This report delivers a comprehensive overview of the Global Hemostatic Agents Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Global Hemostatic Agents Market. The Global Hemostatic Agents Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2032.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Material
3.2. Snippet by Form
3.3. Snippet by Route of Administration
3.4. Snippet by Application
3.5. Snippet by End-User
3.6. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of chronic pain conditions
4.1.2. Restraints
4.1.2.1. Adverse effects and safety concerns associated with Hemostatic Agents
4.1.3. Opportunity
5. IMPACT ANALYSIS
6. INDUSTRY ANALYSIS
6.1. Porter’s Five Force Analysis
6.2. Supply Chain Analysis
6.3. Pricing Analysis
6.4. Patent Analysis
6.5. Regulatory Analysis
6.6. SWOT Analysis
6.7. Unmet Needs
7. BY MATERIAL
7.1. Introduction
7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Material
7.1.2. Market Attractiveness Index, By Material
7.2. Chitosan-based*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Gelatine-based
7.4. Collagen-based
7.5. Oxidized Regenerated Cellulose (ORC)
7.6. Flowable Hemostats
7.7. Others
8. BY FORM
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pain Type
8.1.2. Market Attractiveness Index, By Pain Type
8.2. Powder*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Gel
8.4. Sponges
8.5. Matrix
8.6. Sheets & Pads
9. BY ROUTE OF ADMINISTRATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
9.1.2. Market Attractiveness Index, By Route of Administration
9.2. Topical*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Intravenous
9.4. Others
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. General Surgery*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Cardiovascular Surgery
10.4. Orthopedic Surgery
10.5. Others
11. BY END-USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Hospitals*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Clinics
11.4. Diagnostic Laboratories
11.5. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Spain
12.3.8.5. Italy
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. South Korea
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Becton, Dickinson, and Company*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Aegis Lifesciences
14.3. Baxter
14.4. Teleflex Incorporated
14.5. Johnson & Johnson Services, Inc.
14.6. Pfizer Inc.
14.7. 3-D Matrix Medical Technology
14.8. Medcura
14.9. Ferrosan Medical Devices A/S
14.10. Delta Surgical (LIST NOT EXHAUSTIVE)
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Material
3.2. Snippet by Form
3.3. Snippet by Route of Administration
3.4. Snippet by Application
3.5. Snippet by End-User
3.6. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of chronic pain conditions
4.1.2. Restraints
4.1.2.1. Adverse effects and safety concerns associated with Hemostatic Agents
4.1.3. Opportunity
5. IMPACT ANALYSIS
6. INDUSTRY ANALYSIS
6.1. Porter’s Five Force Analysis
6.2. Supply Chain Analysis
6.3. Pricing Analysis
6.4. Patent Analysis
6.5. Regulatory Analysis
6.6. SWOT Analysis
6.7. Unmet Needs
7. BY MATERIAL
7.1. Introduction
7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Material
7.1.2. Market Attractiveness Index, By Material
7.2. Chitosan-based*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Gelatine-based
7.4. Collagen-based
7.5. Oxidized Regenerated Cellulose (ORC)
7.6. Flowable Hemostats
7.7. Others
8. BY FORM
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Pain Type
8.1.2. Market Attractiveness Index, By Pain Type
8.2. Powder*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Gel
8.4. Sponges
8.5. Matrix
8.6. Sheets & Pads
9. BY ROUTE OF ADMINISTRATION
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
9.1.2. Market Attractiveness Index, By Route of Administration
9.2. Topical*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Intravenous
9.4. Others
10. BY APPLICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. General Surgery*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Cardiovascular Surgery
10.4. Orthopedic Surgery
10.5. Others
11. BY END-USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Hospitals*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Clinics
11.4. Diagnostic Laboratories
11.5. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Spain
12.3.8.5. Italy
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. South Korea
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Becton, Dickinson, and Company*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Aegis Lifesciences
14.3. Baxter
14.4. Teleflex Incorporated
14.5. Johnson & Johnson Services, Inc.
14.6. Pfizer Inc.
14.7. 3-D Matrix Medical Technology
14.8. Medcura
14.9. Ferrosan Medical Devices A/S
14.10. Delta Surgical (LIST NOT EXHAUSTIVE)
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
